🧠 Focus, memory & cognition
6 mechanistic pathways · 102 options
'Nootropic' is a marketing word covering at least six unrelated mechanisms. Acetylcholine is not dopamine is not BDNF is not mitochondrial ATP. Work out whether your problem is attention, recall, mental stamina or brain fog — they respond to different pathways, and stacking across pathways is where the real gains are.
The pathways
Cholinergic — attention, encoding & recall
Acetylcholine is the neurotransmitter of attention and memory formation. Most racetams increase acetylcholine turnover without supplying more, which is exactly why people get headaches on them and why a choline source is not optional in this pathway.
Glutamatergic & synaptic plasticity
Long-term potentiation — the cellular basis of learning — runs through AMPA and NMDA receptors. Modulating them raises the ceiling on how readily new connections form, and it is also the pathway where excitotoxicity is a real rather than theoretical concern.
BDNF & neurotrophic signaling
BDNF is the growth factor for neurons — it supports survival, differentiation and synaptic plasticity. Raising it is the most durable form of cognitive enhancement because it changes the structure rather than borrowing against tomorrow's neurotransmitters.
Catecholamine & dopaminergic drive
Dopamine and noradrenaline set motivation, drive and the ability to start. This is the pathway that feels like something — which is also why it's the one with tolerance, crash and dependency built into the mechanism.
Cerebral metabolism & blood flow
The brain is 2% of body weight and 20% of resting energy use. Brain fog is very often a fuel and perfusion problem rather than a neurotransmitter one, and it responds to a completely different set of tools.
Neuroinflammation & membrane integrity
Persistent brain fog with no attention deficit is often glial inflammation rather than a neurotransmitter shortfall. Microglia stuck in an activated state degrade cognition in a way stimulants paper over and do not fix.
Test before you choose a pathway
Every route below can be argued for on mechanism. Only bloodwork tells you which one is actually your problem — and picking the wrong pathway is the most common reason someone concludes "none of this works". Across all 6 pathways, these are the 20 markers worth having in front of you first.
Ordered together:
🧠 Brain Fog & Cognition🧠 Cognitive Decline & Alzheimer's RiskWhat actually decides this outcome, in order of size
The best evidence on this goal is about risk over decades, and it names fourteen things, none of which is on a shelf. Ranked by how much of the outcome each one owns:
- The modifiable risk factors, which are the largest identified lever and the least commercial. The 2024 report of the Lancet standing Commission on dementia prevention, intervention and care sets out fourteen modifiable risk factors across the life course Livingston 2024. Hearing, blood pressure, education, alcohol, smoking, head injury, air pollution, social contact and physical activity are in that list. No nootropic is.
- What the complaint actually is, because they route differently. Losing the thread of a sentence, losing names, losing motivation and losing the ability to hold effortful attention are four different complaints with four different substrates, and the six pathways below split along those lines rather than along ingredient categories.
- Whether sleep is the cause, which it very often is. Sleep-disordered breathing was estimated at 936 million adults aged 30 to 69 worldwide Benjafield 2019, and it produces exactly the inattentive, word-finding, unrefreshed picture that gets treated as a cholinergic problem. It is a sleep study rather than a purchase.
- Whether a reversible medical cause is present, because those are cheap to exclude. B12 and folate deficiency, hypothyroidism, anemia, uncontrolled glycemia and depression all reproduce cognitive complaints and all appear on one requisition.
- The compounds, last, and the largest trials of the most-sold ones are null or small. Ginkgo biloba did not prevent dementia in a large randomized trial DeKosky 2008. A multivitamin produced a cognitive signal in a randomized program Baker 2022 which has since been meta-analyzed Vyas 2024 and replicated for memory Yeung 2023. That is the honest top of the shelf: a small effect from the cheapest product on it.
The order to run these in, and what has to be true first
Address the fourteen before the six. Then exclude the reversible causes, then choose one pathway. The order is the opposite of how this hub is usually shopped.
- Start with hearing, blood pressure and alcohol, because they are on the list with the evidence. A hearing test and a home blood pressure monitor cost less than one month of most of the shelves below and they appear in the Commission's fourteen Livingston 2024. This is the highest-value action available from this hub and it is not a purchase from it.
- One draw for the reversible causes. Vitamin B12 with Folate, Serum, Methylmalonic Acid (MMA) if B12 is borderline, TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine), Complete Blood Count (CBC) with Differential with Ferritin, HbA1c (Hemoglobin A1c) and Vitamin D (25-Hydroxy). A normal set closes five questions at once.
- Answer the sleep question before buying a stimulant. Snoring with witnessed pauses, morning headache or unrefreshing sleep at a normal duration is a sleep study Benjafield 2019, and treating that changes cognition more than anything in the six pathways.
- Then route to exactly one pathway. Attention and encoding is Cholinergic — attention, encoding & recall. Plasticity and learning is Glutamatergic & synaptic plasticity. Growth factor signaling is BDNF & neurotrophic signaling. Drive and motivation is Catecholamine & dopaminergic drive. Perfusion and fuel is Cerebral metabolism & blood flow. Membrane and glial biology is Neuroinflammation & membrane integrity.
- Greens Powder and a plain multivitamin are the unglamorous top of the shelf. The cognitive signal is small and it is the only one on this hub that has survived a randomized design at scale Baker 2022 Vyas 2024 Yeung 2023.
- Omega-3 (Fish Oil) and the membrane arm sit with the nutritional evidence rather than the nootropic evidence. A 36-month multinutrient trial in prodromal Alzheimer's disease is the most ambitious test of that idea Soininen 2021, and it is a different population from a well 40-year-old who wants to concentrate.
- Ginkgo Biloba is where a reader should update. The prevention trial was large, long and negative DeKosky 2008. A product that survives that result on reputation alone is the clearest example on this hub of marketing outliving evidence.
- Fix the measurement before running the experiment. Choose one cognitive task, practice it to a stable score before starting anything, and only then begin. Skipping this step guarantees that improvement from familiarity will be read as improvement from the product.
What gets bought for this that cannot move it
The category that fails structurally is the nootropic bought to prevent decline. Prevention is a decades-long endpoint and the evidence for it is epidemiological and interventional at the level of risk factors Livingston 2024. No compound on the six pathways below has ever been tested against that endpoint, and the one that was tested properly failed DeKosky 2008. Acute attention and long-term risk are different goals sold as one.
The measurement problem here is worse than on any other hub. Cognitive tests improve on repetition because the person learns the test. An unblinded self-experiment with a new supplement and a new task will produce improvement whatever is in the capsule, and that is not a weakness of the reader's discipline; it is a property of the instrument.
And the blood biomarkers that do exist are not screening tests. Plasma Alzheimer's disease biomarkers vary for reasons unrelated to amyloid Lee 2024, and preanalytical delay alone changes their measured performance Delaby 2025. A well person ordering pTau-217 (AD-Detect) out of curiosity is buying a result they have no framework for and cannot act on.
If the complaint has a different shape, so does the goal. Fatigue rather than fogginess is Energy & fatigue. Low mood with anhedonia is Mood & stress resilience. Word-finding and concentration that arrived with a life event is stress and sleep rather than a receptor. And new, progressive memory loss noticed by other people is a clinical assessment, not a supplement.
How you would know it was working, on a real read-out and a real timescale
The prediction this hub makes is that the reversible causes will either be found on one panel or excluded by it, and that a supplement effect will not survive a stabilized cognitive task. If the panel is normal and a practiced task does not improve, nothing on the six pathways is doing what it was bought for.
- Vitamin B12 with Folate, Serum, and Methylmalonic Acid (MMA) if B12 is borderline. Methylmalonic acid rises when cobalamin is functionally insufficient at the tissue, which is exactly what a borderline serum B12 cannot resolve. Homocysteine adds the functional read-out of the remethylation step.
- TSH (Thyroid-Stimulating Hormone) with Free T4 (Thyroxine), Complete Blood Count (CBC) with Differential with Ferritin, and HbA1c (Hemoglobin A1c) once each. These are the reversible causes, and a normal set is the finding rather than a wasted test.
- A single cognitive task, practiced to a plateau before baseline. Digit span, a paced serial addition task, or a fixed reaction-time test. The plateau requirement is what removes the practice effect, and without it the read-out measures familiarity.
- pTau-217 (AD-Detect) only with a clinical question and a clinician, never as a curiosity. Plasma biomarker values move with kidney function, body mass and sample handling Lee 2024 Delaby 2025, and an isolated result in a well person changes nothing except anxiety.
- 8 to 12 weeks before a verdict, and the number has a reason. Nutritional corrections act over weeks, and the randomized cognitive signals on this hub were detected over months rather than days Vyas 2024. Judging at one week measures caffeine and expectation.
What will fool you. Every cognitive test improves with repetition, so an unpracticed baseline guarantees a positive result. Sleep and stress move attention more than any product on this hub, and both usually change in the same week a supplement is started. Caffeine taken with a nootropic takes the credit for it. Season, daylight and a resolved winter infection all matter. And the multivitamin evidence Baker 2022 is a small average effect in a large randomized population, which is not the same as a noticeable effect in one person.
Sources read for these sections
- Livingston G. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet 2024 · PMID 39096926
- DeKosky ST, Williamson JD, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA 2008 · PMID 19017911
- Baker LD, et al. Effects of cocoa extract and a multivitamin on cognitive function: a randomized clinical trial.. Alzheimer's & Dementia 2022 · PMID 36102337
- Vyas CM, et al. Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial and meta-analysis of 3 cognitive studies within COSMOS.. American Journal of Clinical Nutrition 2024 · PMID 38244989
- Yeung LK. Multivitamin supplementation improves memory in older adults: a randomized clinical trial. American Journal of Clinical Nutrition 2023 · PMID 37244291
- Benjafield AV. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respiratory Medicine 2019;7(8):687-698 · PMID 31300334
- Lee EH, et al. Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors. Alzheimer's and Dementia 2024 · PMID 39535473
- Delaby C, et al. Impact of preanalytical delay on the performance of plasma Abeta42, Abeta42/40, p-tau217, and p-tau217/Abeta42 in detecting brain amyloidosis in the ALZAN cohort. Alzheimer's and Dementia 2025 · PMID 41166452
- Soininen H, Solomon A, et al. 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease. Alzheimer's & Dementia 2021 · PMID 32920957
You have the pathways. Here is the stack.
The Cognition Blueprint names the one compound I would start with in each of these 6 pathways, what it was chosen over, and why — plus 30 options to swap in or stack on top, every one of them priced and linked.
Open The Cognition Blueprint →You know the goal. Skool has the plan.
Every pathway above is one arm of The Focus, memory & cognition Blueprint. The members' version has the sequence they run in, what stacks with what, and the markers that tell you to keep going or stop — alongside the Bloodwork Protocols.
Open The Focus, memory & cognition Blueprint in Skool →$10/mo, cancel anytime.
← Open Focus, memory & cognition in the interactive Vault · All 21 goals
Frequently asked questions
This goal is broken into 6 distinct mechanistic pathways — Cholinergic — attention, encoding & recall; Glutamatergic & synaptic plasticity; BDNF & neurotrophic signaling; Catecholamine & dopaminergic drive and others — across 102 compounds and supplements. Each pathway is a different argument about how the body gets there, so the useful question is which one matches where you are actually stuck.
The one that matches your actual limitation, which bloodwork usually settles faster than guessing. An appetite drug does nothing for someone who already undereats, and a thyroid intervention does nothing if your thyroid is fine. Each pathway page lists the markers that tell you whether it is your problem.
No. The 6 pathways are listed in mechanistic order, not by strength of evidence, and neither are the 102 options inside them. A lot of what works in this space has never had the trial run, and sorting by trial count would bury exactly the compounds you came looking for.
Where this goes next
Everything above is the free case for Focus, memory & cognition. The protocol — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.